Results 181 to 190 of about 48,920 (278)

Transgenic selection and underlying mechanisms in apicomplexan parasites

The FEBS Journal, EarlyView.
Transgenic selection markers have driven genetic engineering in apicomplexans, enabling precise, iterative experiments. This review discusses mechanistic details of drug selection markers, strategies for marker recycling, and practical considerations for several clinically relevant parasites.
Swaroop Peddiraju, Rakhee Lohia, Nishith Gupta   +2 more
wiley   +1 more source

Editorial: Bacteriophage therapy in orthopedics-Key questions and emerging answers. [PDF]

J Orthop Traumatol
Migliorini F, Rivera F, Eschweiler J.
europepmc   +1 more source

Staphylococcus aureus Sb‐1 Bacteriophage Alters Frequency and Subset Distribution of Human Innate Lymphoid Cells

Allergy, EarlyView.
Ramazan Rozumbetov, Ismail Ogulur, Anja Heider, Anna Globinska, Nina Chanishvili, Elene Kakabadze, Marina Goderdzishvili, Nino Grdzelishvili, Nata Bakuradze, Moelong Yu, Tamara Aripova, Adolat Ismailova, Nikolaos Papadopoulos, Mubeccel Akdis, Cezmi A. Akdis   +14 more
wiley   +1 more source

A guide to the ecological limitations of phage therapy of bacterial biofilms: Is what's best for the phage best for the physician?

The FEBS Journal, EarlyView.
Bacteriophages—viruses that kill bacteria—are promising weapons against bacterial biofilms: sessile communities notoriously resistant to antibiotics. Yet phages evolved not so much to eradicate bacteria as to obtain new bacteria to infect. That goal, however, may conflict with the physician's objective of complete bacterial clearance.
Stephen T. Abedon
wiley   +1 more source

Clinical and Translational Perspectives on Bacteriophage Therapy for Nontuberculous Mycobacterial Diseases. [PDF]

J Microbiol Biotechnol
Ash A, Moon C, Jang J.
europepmc   +1 more source

Exploring Bacteriophage Therapy Against Pseudomonas aeruginosa in Paediatric Cystic Fibrosis: Early-Phase Clinical Trial Implementation

This thesis investigates bacteriophage therapy as a treatment for Pseudomonas aeruginosa infections in children with cystic fibrosis (CF). Despite significant advances in CF, P.
Singh, Jagdev
core  

Gene Editing for Haemophilia—The Next Frontier

Haemophilia, EarlyView.
ABSTRACT The recently approved haemophilia A and B gene therapies via adeno‐associated virus (AAV) showed a promising therapeutic response after a single injection, but there are still limitations, including the potential loss of transgene expression and restriction in adults.
Mirko Pinotti, Gregory A. Newby, Sundar Selvaraj, Steven W. Pipe   +3 more
wiley   +1 more source

Bacteriophage Therapy: Overcoming Antimicrobial Resistance Through Advanced Delivery Methods. [PDF]

Molecules
Wacnik M, Hauza E, Skaradzińska A, Śliwka P.   +3 more
europepmc   +1 more source

Innovative Field Applications of Probiotics, Prebiotics, and Medicinal Plant Products for Disease Control in Aquaculture

Journal of Fish Diseases, EarlyView.
ABSTRACT Disease outbreaks and the associated reliance on antibiotics pose major constraints to the sustainability of modern aquaculture. As regulatory pressures increase and consumer demand shifts toward residue‐free production, diverse biological interventions are gaining prominence as viable alternatives to chemotherapeutics.
Mustafa Öz, Enes Üstüner, Sümmani Çifci, Suat Dikel, Emin İleri, Furkan Budak   +5 more
wiley   +1 more source

Bacteriophage Therapy in Selected Disease Entities: A Review of the Literature. [PDF]

Cureus
Dudek A, Bursy M, Szkudlarek W, Linkiewicz J, Starosta P, Fabiszewski Z, Grabinska M.   +6 more
europepmc   +1 more source